Nabity-Jensen Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Nabity-Jensen Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$670K	Hold	1,348	–	–	0.41%	44
2026 Q1	$602K	Hold	1,348	–	–	0.42%	40
2025 Q4	$611K	Hold	1,348	–	–	0.41%	41
2025 Q3	$528K	Hold	1,348	–	–	0.37%	43
2025 Q2	$600K	Hold	1,348	–	–	0.44%	44
2025 Q1	$654K	Hold	1,348	–	–	0.52%	42
2024 Q4	$543K	Hold	1,348	–	–	0.41%	45
2024 Q3	$627K	Hold	1,348	–	–	0.48%	42
2024 Q2	$632K	Hold	1,348	–	–	0.52%	35
2024 Q1	$563K	Hold	1,348	–	–	0.46%	41
2023 Q4	$548K	Buy	+1,348	New	+$498K	0.49%	39

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Nabity-Jensen Investment Management's VRTX Position: Q2 2026 in Review

Nabity-Jensen Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,348 shares worth $670K. The position accounts for 0.41% of the portfolio, ranked #44.

Nabity-Jensen Investment Management first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 528 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Nabity-Jensen Investment Management held 1,348 shares of Vertex Pharmaceuticals worth $670K as of Q2 2026.
Nabity-Jensen Investment Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.41% of Nabity-Jensen Investment Management's portfolio in Q2 2026, its #44 holding.
Nabity-Jensen Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
528 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Nabity-Jensen Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.